BREAKING NEWS for email followers
There’s a lot of questions doing the rounds on forums and messages about the approval of Lutathera (PRRT) in USA, Europe and other places. The latest we know is in the red print headlines below. Followed by an update of known activity by region/country and a short primer for those not sure about PRRT.
USA – 26 Jan 2018. FDA approves Lutetium Lu 177 Dotatate (Lutathera®) CLICK HERE
See also here
(full guidance will be updated when received)
ALL – 7 Dec 2017. Novartis and Advanced Accelerator Applications (AAA) Announced that Novartis is buying AAA and the process has been completed. AAA is now a Novartis Company. Read here This will not have any effect on approval timelines.
EUROPE – 29 Sep 2017. AAA Announced that the European Commission (EC) has approved the use of Lutetium Lu 177 Dotatate (Lutathera®). Despite the treatment being used…
View original post 1,384 more words